In-Home Evaluation of Episodic Administration of Palovarotene in Fibrodysplasia Ossificans Progressiva (FOP) Subjects
Clinical trial NCT02521792 · TERMINATED
Trial details
- NCT number
- NCT02521792
- Sponsor
- Clementia Pharmaceuticals Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-07
- Primary completion
- 2016-08-04
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.